Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.20.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income / Loss [Member]
Total
Beginning balance, shares at Mar. 31, 2018 0 685,747        
Beginning balance, amount at Mar. 31, 2018 $ 0 $ 1 $ 176,740 $ (157,440) $ (3,975) $ 15,326
Rounding adjustment related to 1 for 9 common stock split, effected June 19, 2019   (1,442)        
Issuance of common stock, net of offering costs, shares   29,710        
Issuance of common stock, net of offering costs, value     957     957
Issuance of common stock and common stock purchase warrants, net of commissions, expenses and other offering costs, shares   507,156        
Issuance of common stock and common stock purchase warrants, net of commissions, expenses and other offering costs, value   $ 1 3,881     3,882
Issuance of Series B convertible preferred stock, net of commissions, expenses and other offering costs, shares 10          
Issuance of Series B convertible preferred stock, net of commissions, expenses and other offering costs, value     861     861
Conversion of Series B convertible preferred stock into common stock, preferred stock converted shares (8)          
Conversion of Series B convertible preferred stock into common stock, common stock issued   90,000        
Issuance of common stock for service fees, shares   2,736        
Issuance of common stock for service fees, value     59     59
Stock based compensation related to issuance of common stock restricted stock grants, shares   2,428        
Stock based compensation related to issuance of common stock restricted stock grants, value     117     117
Stock-based compensation expense, net of forfeitures     1,459     1,459
Foreign currency translation adjustment         (374) (374)
Net loss       (11,798)   (11,798)
Ending balance, shares at Mar. 31, 2019 2 1,316,335        
Ending balance, amount at Mar. 31, 2019 $ 0 $ 2 184,074 (169,238) (4,349) 10,489
Cumulative adjustment to April 1, 2017 resulting from adoption of ASU No. 2016-09 (62) (62)
Issuance of common stock, net of offering costs, shares 446,577        
Issuance of common stock, net of offering costs, value 1,376 1,376
Reclassification of stock liability to equity, shares 12,556        
Reclassification of stock liability to equity, value 270 270
Stock based compensation related to issuance of common stock restricted stock grants, shares 2,015        
Stock based compensation related to issuance of common stock restricted stock grants, value 38 38
Stock-based compensation expense, net of forfeitures 801   801
Foreign currency translation adjustment (1,261) (1,261)
Net loss (2,946) (2,946)
Ending balance, shares at Mar. 31, 2020 2 1,777,483        
Ending balance, amount at Mar. 31, 2020 $ 2 $ 186,559 $ (172,246) $ (5,610) $ 8,705